Lilly in Boston, Massachusetts

Boston Research & Development

Our presence in Boston is growing across our two sites based in the Seaport area of Boston: Lilly Seaport Innovation Center (LSC) and Lilly Harborside Research & Development Labs (LHL). These research and development facilities are dedicated to advancing Lilly's efforts in RNA and DNA-based therapies as well as discovering new drug targets to create life-changing medicines across several disease states, including diabetes, obesity, cardiovascular diseases, neurodegeneration, chronic pain, immunology and hearing health.
In addition to Research & Development, LSC also houses the east coast location of Lilly's shared innovation accelerator, Lilly Gateway Labs, which provides participating companies with state-of-the-art lab space and unique access to Lilly scientists, researchers and executives, as well as exposure to Lilly's functional and scientific expertise.

Lilly Seaport Innovation Center

LillyBostonVideothumbnail
The Lilly Seaport Innovation Center in Boston, Massachusetts, is where cutting-edge genetic medicine meets breathtaking views. This facility is dedicated to advancing medicine through scientific progress and breakthroughs, with a strong focus on serving both its employees and patients.